Hepatic fibrosis is a reparative response of diffuse over-deposition and abnormal distribution of extracellular matrix (collagen, glycoprotein and proteoglycans) after exposure to various kinds of liver injuries, and is a key step in the developmental process of various chronic liver diseases leading to cirrhosis. Recently, many advances in our understanding of hepatic fibrosis have been obtained through basic and clinical research. Therefore, this consensus summarizes and offers 15 evidence-based recommendations on the diagnosis and evaluation of hepatic fibrosis, its treatment, drug development and applications.
第一作者单位:[1]Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Gastroenterol, Sch Med, 85-86 Wujin Rd, Shanghai 200080, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Lu Lun Gen,You Hong,Xie Wei Fen,et al.Consensus on the diagnosis and treatment of hepatic fibrosis (2019)[J].JOURNAL of DIGESTIVE DISEASES.2020,21(3):127-138.doi:10.1111/1751-2980.12854.
APA:
Lu, Lun Gen,You, Hong,Xie, Wei Fen&Jia, Ji Dong.(2020).Consensus on the diagnosis and treatment of hepatic fibrosis (2019).JOURNAL of DIGESTIVE DISEASES,21,(3)
MLA:
Lu, Lun Gen,et al."Consensus on the diagnosis and treatment of hepatic fibrosis (2019)".JOURNAL of DIGESTIVE DISEASES 21..3(2020):127-138